Erratum: Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes. A randomized, double-blind, placebo-controlled clinical trial

摘要

The authors of an article published in the February 2013 issue of the Journal notified us of errors in Table 2.The article is by Todd M. Durrell MD, Lenard A. Adler, MD, Dave W. Williams, MS, et al, and is titled Atomoxetine Treatment of Attention-Deficit/Hyperaclivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (J Clin Psychopharmacol. 2013;33:45-54).